Lymphoma: Customized therapeutic delivery

Nature Reviews Cancer 16, 756 (2016). doi:10.1038/nrc.2016.121 Author: Sarah Seton-Rogers Boice, Salloum, Mourcin et al. show that HVEM is an important tumour suppressor in lymphomas and that direct delivery of a soluble HVEM peptide using engineered T cells might be therapeutically beneficial.
Source: Nature Reviews Cancer - Category: Cancer & Oncology Authors: Tags: Research Highlight Source Type: research